https://www.selleckchem.com/pr....oducts/brigatinib-ap
The potential of GHB conjugates has been investigated in a variety of clinical settings. Despite the recent growth in the application of metabolomics and metabolism studies associated with GHB exposure, it remains challenging to distinguish between endogenous and exogenous GHB. This review highlights the significance of further metabolomics and metabolism studies for the discovery of practical peripheral biomarkers of GHB exposure.Bone metastases from prostate cancer (PCa) often show an increase in density on computed tomogra
Curtir
Comentario
Compartilhar
